What is Sarepta Therapeutics, Inc.'s operating income?

Sarepta Therapeutics, Inc. (SRPT) reported operating income of -$300.39M in Q1 2025.

How has Sarepta Therapeutics, Inc.'s operating income changed year-over-year?

Sarepta Therapeutics, Inc.'s operating income decreased by 960.6% year-over-year, from $34.91M to -$300.39M.

What does operating income mean?

Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Sarepta Therapeutics, Inc. SRPT Operating Income

Discontinued — last reported Q1 '25

Operating Income at other companies

Regeneron PharmaceuticalsREGN

$642.9M+8.7%

BioMarin PharmaceuticalsBMRN

$129.64M-42.1%

PTC TherapeuticsPTCT

$44.96M-95.4%

InsmedINSM

-$153.32M+38.2%

Capricor TherapeuticsCAPR

-$36.77M-47.2%

Catalyst PharmaceuticalCPRX

$73.23M+15.6%

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.82B-63.1%

Enterprise value$1.56B-67.2%

P/S0.8×—

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s operating income?: Sarepta Therapeutics, Inc. (SRPT) reported operating income of -$300.39M in Q1 2025.
How has Sarepta Therapeutics, Inc.'s operating income changed year-over-year?: Sarepta Therapeutics, Inc.'s operating income decreased by 960.6% year-over-year, from $34.91M to -$300.39M.
What does operating income mean?: Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.